Showing results (31-40 of 42) with videos related to
Sort By:
Pageof 5
Histology and Histopathology|June 27, 2008
SMARCC1 expression is upregulated in prostate cancer and positively correlated with tumour recurrence and dedifferentiationS Heebøll, M Borre, P D Ottosen, et al.Biosensors & Bioelectronics|November 1, 2005
dc-Sheet resistance as sensitive monitoring tool of protein immobilization on thin metal filmsH Neff, T Beeby, A M N Lima, et al.Acta Tropica|June 1, 1992
The antibody response to well-defined malaria antigens after acute malaria in individuals living under continuous malaria transmissionE Petersen, B Høgh, M Dziegiel, et al.Acta Tropica|September 1, 1994
The influence of Maloprim chemoprophylaxis on cellular and humoral immune responses to Plasmodium falciparum asexual blood stage antigens in schoolchildren living in a malaria endemic area of MozambiqueB Hogh, R Thompson, V Lobo, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Training and validation of a novel 4-miRNA ratio model (MiCaP) for prediction of postoperative outcome in prostate cancer patientsL Schmidt, J Fredsøe, H Kristensen, et al.British Journal of Cancer|January 17, 2013
Prognostic significance of aberrantly silenced ANPEP expression in prostate cancerK D Sørensen, M O Abildgaard, C Haldrup, et al.Oncogene|November 17, 2009
miR-145 induces caspase-dependent and -independent cell death in urothelial cancer cell lines with targeting of an expression signature present in Ta bladder tumorsM S Ostenfeld, J B Bramsen, P Lamy, et al.British Journal of Cancer|October 8, 2011
Low ANXA10 expression is associated with disease aggressiveness in bladder cancerP P Munksgaard, F Mansilla, A-S Brems Eskildsen, et al.British Journal of Cancer|November 24, 2011
The miR-143/-145 cluster regulates plasminogen activator inhibitor-1 in bladder cancerS B Villadsen, J B Bramsen, M S Ostenfeld, et al.Oncogene|August 29, 2012
A high resolution genomic portrait of bladder cancer: correlation between genomic aberrations and the DNA damage responseT Schepeler, P Lamy, V Hvidberg, et al.Pageof 5